PRECISION NURSING: PERSONALIZATION OF NEONATAL CARE BASED ON REGENERATIVE BIOMARKERS OF CARDIOVASCULAR CARE

Authors

  • Andréa Martins Colares da Silva Author
  • Emanuela Almeida Sobral Author
  • Lucas Zango Angeli Lima Author
  • Eduarda Galdino Dal Bosco Author
  • Maria Eridan Barreto Lima Author
  • Janaína Ferreira de Sousa Author
  • Aline Maria Castro Reis Author
  • Thamiles Andrade Santiago Author

Keywords:

Precision Nursing, Biomarkers, Neonatal Care

Abstract

Precision nursing emerges as a strategic field for transforming healthcare, especially in neonatology, where the vulnerability of newborns demands highly individualized approaches. Grounded in the principles of precision medicine, this perspective considers genomic, epigenetic, environmental, and social factors to guide more accurate clinical decisions. In the neonatal context, the use of biomarkers has stood out as a promising tool to anticipate risks, monitor therapeutic responses, and promote personalized care, contributing to improved short- and long-term outcomes. Among the biomarkers with greater clinical relevance are those related to the cardiovascular system, such as troponins, natriuretic peptides, and microRNAs, which enable the early detection of functional and structural alterations. Recent studies also highlight the role of regenerative biomarkers in the prevention and recovery of cardiovascular dysfunctions in at-risk neonates, opening new perspectives for innovative therapies and more precise clinical monitoring (CALZONE; JENKINS; FEERO, 2013; MANOLIO et al., 2020). In this scenario, the nurse assumes a central role not only in clinical monitoring but also in the interpretation of biomolecular data and the integration of this information into personalized care plans. Moreover, the nursing professional acts as a bridge between technology and humanization, ensuring that the use of advanced resources respects ethical principles and the uniqueness of each patient. Thus, precision nursing applied to neonatal care, with a focus on cardiovascular biomarkers, represents an innovative and necessary horizon for contemporary clinical practice. By integrating science, technology, and humanized care, it paves the way for a regenerative approach to care capable of promoting better prognoses and contributing to the consolidation of a fairer, more equitable, and sustainable health model.

DOI: https://doi.org/10.56238/edimpacto2025.091-003

Published

2025-10-06